Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro

I. V. Balalaeva, E. A. Sokolova, A. D. Puzhikhina, A. A. Brilkina, S. M. Deyev

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Tumor response to therapeutic treatment is largely determined by its heterogeneity and the presence of intercellular junctions, hindering the penetration of large molecules deep into the three-dimensional structure of the tumor. In that context, 3D in vitro tumor models such as cancer cell spheroids are becoming increasingly popular. We obtained spheroids of human breast adenocarcinoma SKBR-3 overexpressing the HER2 cancer marker. The toxicity of HER2-targeted immunotoxin 4D5scFv-PE40 against spheroids was shown to be several orders of magnitude lower compared to a monolayer cell culture. The significant difference in the severity of the immunotoxin effect can be explained by the fact that it ineffectively penetrates the spheroid and predominantly influences the cells of the outer layers. The resulting tumor spheroid model can be used in development of drugs for targeted therapy as well as to study ways to improve the efficiency of anticancer agents by targeting cell-cell contacts. 2017 Park-media, Ltd.

Original languageEnglish
Pages (from-to)38-43
Number of pages6
JournalActa Naturae
Volume9
Issue number1
Publication statusPublished - 2017

Fingerprint

Immunotoxins
Tumors
Adenocarcinoma
Breast
Neoplasms
Cell culture
Antineoplastic Agents
Toxicity
Monolayers
Intercellular Junctions
Cells
Molecules
In Vitro Techniques
Cell Culture Techniques
Pharmaceutical Preparations
Drug Therapy
Therapeutics

Keywords

  • 4D5scFv-PE40 immunotoxin
  • Cancer marker HER2
  • Drug penetration into tumor
  • Spheroids
  • Targeted therapy

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

Balalaeva, I. V., Sokolova, E. A., Puzhikhina, A. D., Brilkina, A. A., & Deyev, S. M. (2017). Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro. Acta Naturae, 9(1), 38-43.

Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro. / Balalaeva, I. V.; Sokolova, E. A.; Puzhikhina, A. D.; Brilkina, A. A.; Deyev, S. M.

In: Acta Naturae, Vol. 9, No. 1, 2017, p. 38-43.

Research output: Contribution to journalArticle

Balalaeva, IV, Sokolova, EA, Puzhikhina, AD, Brilkina, AA & Deyev, SM 2017, 'Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro', Acta Naturae, vol. 9, no. 1, pp. 38-43.
Balalaeva, I. V. ; Sokolova, E. A. ; Puzhikhina, A. D. ; Brilkina, A. A. ; Deyev, S. M. / Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro. In: Acta Naturae. 2017 ; Vol. 9, No. 1. pp. 38-43.
@article{9fe8c7a8db3e4efcb2c825b8e8a7af83,
title = "Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro",
abstract = "Tumor response to therapeutic treatment is largely determined by its heterogeneity and the presence of intercellular junctions, hindering the penetration of large molecules deep into the three-dimensional structure of the tumor. In that context, 3D in vitro tumor models such as cancer cell spheroids are becoming increasingly popular. We obtained spheroids of human breast adenocarcinoma SKBR-3 overexpressing the HER2 cancer marker. The toxicity of HER2-targeted immunotoxin 4D5scFv-PE40 against spheroids was shown to be several orders of magnitude lower compared to a monolayer cell culture. The significant difference in the severity of the immunotoxin effect can be explained by the fact that it ineffectively penetrates the spheroid and predominantly influences the cells of the outer layers. The resulting tumor spheroid model can be used in development of drugs for targeted therapy as well as to study ways to improve the efficiency of anticancer agents by targeting cell-cell contacts. 2017 Park-media, Ltd.",
keywords = "4D5scFv-PE40 immunotoxin, Cancer marker HER2, Drug penetration into tumor, Spheroids, Targeted therapy",
author = "Balalaeva, {I. V.} and Sokolova, {E. A.} and Puzhikhina, {A. D.} and Brilkina, {A. A.} and Deyev, {S. M.}",
year = "2017",
language = "English",
volume = "9",
pages = "38--43",
journal = "Acta Naturae",
issn = "2075-8251",
publisher = "Park Media Ltd.",
number = "1",

}

TY - JOUR

T1 - Spheroids of her2-positive breast adenocarcinoma for studying anticancer immunotoxins in vitro

AU - Balalaeva, I. V.

AU - Sokolova, E. A.

AU - Puzhikhina, A. D.

AU - Brilkina, A. A.

AU - Deyev, S. M.

PY - 2017

Y1 - 2017

N2 - Tumor response to therapeutic treatment is largely determined by its heterogeneity and the presence of intercellular junctions, hindering the penetration of large molecules deep into the three-dimensional structure of the tumor. In that context, 3D in vitro tumor models such as cancer cell spheroids are becoming increasingly popular. We obtained spheroids of human breast adenocarcinoma SKBR-3 overexpressing the HER2 cancer marker. The toxicity of HER2-targeted immunotoxin 4D5scFv-PE40 against spheroids was shown to be several orders of magnitude lower compared to a monolayer cell culture. The significant difference in the severity of the immunotoxin effect can be explained by the fact that it ineffectively penetrates the spheroid and predominantly influences the cells of the outer layers. The resulting tumor spheroid model can be used in development of drugs for targeted therapy as well as to study ways to improve the efficiency of anticancer agents by targeting cell-cell contacts. 2017 Park-media, Ltd.

AB - Tumor response to therapeutic treatment is largely determined by its heterogeneity and the presence of intercellular junctions, hindering the penetration of large molecules deep into the three-dimensional structure of the tumor. In that context, 3D in vitro tumor models such as cancer cell spheroids are becoming increasingly popular. We obtained spheroids of human breast adenocarcinoma SKBR-3 overexpressing the HER2 cancer marker. The toxicity of HER2-targeted immunotoxin 4D5scFv-PE40 against spheroids was shown to be several orders of magnitude lower compared to a monolayer cell culture. The significant difference in the severity of the immunotoxin effect can be explained by the fact that it ineffectively penetrates the spheroid and predominantly influences the cells of the outer layers. The resulting tumor spheroid model can be used in development of drugs for targeted therapy as well as to study ways to improve the efficiency of anticancer agents by targeting cell-cell contacts. 2017 Park-media, Ltd.

KW - 4D5scFv-PE40 immunotoxin

KW - Cancer marker HER2

KW - Drug penetration into tumor

KW - Spheroids

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85017554544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017554544&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85017554544

VL - 9

SP - 38

EP - 43

JO - Acta Naturae

JF - Acta Naturae

SN - 2075-8251

IS - 1

ER -